AVPT vs PAGS

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite solid revenue growth (23.6% YoY) and strong gross margins (74.51%), profitability remains thin with only a 0.50% net margin and weak ROE (0.67%). Analysts recommend a 'buy' with a $19.02 target, implying 51% upside, but insider selling of $89.11M over the last six months contradicts this optimism. The stock trades at a high forward P/E of 32.18, above sector averages, while recent price performance is bearish (-31.3% over 1Y), reflecting market skepticism despite improving earnings trends.

PAGS presents a classic deep-value opportunity, anchored by a strong Piotroski F-Score of 7/9 and a Graham Number of $18.25, which is significantly above the current price of $10.02. While the company is facing a growth slowdown with negative Q/Q revenue and earnings trends, its financial health is robust with very low debt (D/E 0.18) and a highly sustainable 10.38% dividend yield. The extreme valuation discount (P/E 7.06, P/B 0.96) provides a substantial margin of safety that outweighs current technical bearishness. The synthesis of strong health and extreme undervaluation suggests a strong recovery potential.